TrialClinical and translational science2026

Open-Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.

Andy Sykes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.